NCT00559624 - Safety and Tolerability Open Label Dose Escalation Study of Acadesine in B-CLL Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions

Leukemia, B-Cell, Chronic

Interventions

DRUG

Acadesine

For part I of the study one 4 hour intravenous infusion will be given. In part II upto five 4 hour intravenous infusions will be given over 20 days.

Trial Locations (8)

Hospital Madrid Nortesanchinarro, Madrid

Hospital Clinico Universitario de Valencia, Valencia

Hematology Department, ZNA Stuivenberg, Antwerp

Cliniques universitaires Saint-Luc Haematology Dept, Brussels

Hematology Department UZ Gasthuisberg, Leuven

Hôpital Avicenne, Bobigny

Service des maladies du sang Hôpital HURIEZ, CHRU, Lille

Hematologia Clinica, Institut Catala d'Oncologia, Barcelona